Primary |
Nasopharyngitis |
17.8% |
Drug Use For Unknown Indication |
15.6% |
Cough |
13.3% |
Lower Respiratory Tract Infection |
8.9% |
Headache |
6.7% |
Influenza Like Illness |
6.7% |
Bipolar Disorder |
4.4% |
Influenza |
4.4% |
Pyrexia |
4.4% |
Convulsion |
2.2% |
Gastric Disorder |
2.2% |
Hypersensitivity |
2.2% |
Nasal Congestion |
2.2% |
Product Used For Unknown Indication |
2.2% |
Psoriatic Arthropathy |
2.2% |
Rhinorrhoea |
2.2% |
Upper Respiratory Tract Congestion |
2.2% |
|
Pneumonia |
13.3% |
Vomiting |
10.0% |
Chromaturia |
6.7% |
Drug Hypersensitivity |
6.7% |
Hypertension |
6.7% |
Off Label Use |
6.7% |
Swelling Face |
6.7% |
Abdominal Pain Upper |
3.3% |
Cardiac Arrest |
3.3% |
Cardiac Disorder |
3.3% |
Chronic Obstructive Pulmonary Disease |
3.3% |
Constipation |
3.3% |
Convulsion |
3.3% |
Fall |
3.3% |
Hallucination |
3.3% |
Insomnia |
3.3% |
Loss Of Consciousness |
3.3% |
Mania |
3.3% |
Opiates Positive |
3.3% |
Rash Generalised |
3.3% |
|
Secondary |
Headache |
14.0% |
Nasopharyngitis |
12.4% |
Product Used For Unknown Indication |
10.1% |
Drug Use For Unknown Indication |
8.5% |
Pyrexia |
7.8% |
Nausea |
6.2% |
Cough |
5.4% |
Gastrooesophageal Reflux Disease |
4.7% |
Respiratory Tract Congestion |
3.9% |
Acid Reflux (Esophageal) |
3.1% |
Bronchitis |
3.1% |
Cold |
3.1% |
Haemoglobin Decreased |
3.1% |
Premature Labour |
3.1% |
Candidiasis |
2.3% |
Polycystic Ovaries |
2.3% |
Vomiting |
2.3% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Drug Dependence |
1.6% |
Prophylaxis |
1.6% |
|
Hypersensitivity |
14.8% |
Drug Exposure During Pregnancy |
7.4% |
Hallucination |
7.4% |
Somnolence |
7.4% |
Yellow Skin |
7.4% |
Dizziness |
3.7% |
Drug Abuser |
3.7% |
Drug Hypersensitivity |
3.7% |
Hepatocellular Damage |
3.7% |
Ill-defined Disorder |
3.7% |
Intentional Drug Misuse |
3.7% |
Maternal Exposure During Pregnancy |
3.7% |
Myocardial Infarction |
3.7% |
Nausea |
3.7% |
Palpitations |
3.7% |
Pneumonia |
3.7% |
Premature Baby |
3.7% |
Premature Labour |
3.7% |
Throat Irritation |
3.7% |
Toxic Epidermal Necrolysis |
3.7% |
|
Concomitant |
Product Used For Unknown Indication |
20.9% |
Drug Use For Unknown Indication |
9.5% |
Pain |
7.1% |
Cough |
7.0% |
Depression |
7.0% |
Upper Respiratory Tract Infection |
5.0% |
Bronchitis |
4.9% |
Hypertension |
4.8% |
Non-small Cell Lung Cancer |
4.1% |
Anxiety |
3.7% |
Nausea |
3.7% |
Pyelonephritis |
3.5% |
Constipation |
3.1% |
Restless Legs Syndrome |
2.7% |
Acute Lymphocytic Leukaemia |
2.4% |
Back Pain |
2.3% |
Chronic Obstructive Pulmonary Disease |
2.2% |
Sinusitis |
2.1% |
Type 2 Diabetes Mellitus |
2.1% |
Prophylaxis |
2.0% |
|
Vomiting |
21.1% |
Weight Increased |
6.2% |
Wound Infection |
6.2% |
Type 2 Diabetes Mellitus |
5.6% |
Pyrexia |
5.0% |
Urinary Tract Infection |
5.0% |
White Blood Cell Count Increased |
5.0% |
Pneumonia Aspiration |
4.3% |
Therapeutic Agent Toxicity |
4.3% |
Weight Decreased |
4.3% |
Pneumonia |
3.7% |
Sepsis |
3.7% |
Transposition Of The Great Vessels |
3.7% |
Upper Respiratory Tract Infection |
3.7% |
Uveitis |
3.7% |
Pulmonary Valve Stenosis |
3.1% |
Vision Blurred |
3.1% |
Wheezing |
3.1% |
Nausea |
2.5% |
Pleural Effusion |
2.5% |
|
Interacting |
Product Used For Unknown Indication |
15.6% |
Respiratory Tract Congestion |
15.6% |
Depression |
13.3% |
Insomnia |
13.3% |
Abdominal Discomfort |
11.1% |
Hypertension |
11.1% |
Bipolar Disorder |
4.4% |
Gastric Disorder |
4.4% |
Arrhythmia |
2.2% |
Coagulopathy |
2.2% |
Convulsion |
2.2% |
Nasal Congestion |
2.2% |
Nasopharyngitis |
2.2% |
|
Fatigue |
28.6% |
Moaning |
28.6% |
Feeling Abnormal |
14.3% |
Mania |
14.3% |
Somnolence |
14.3% |
|